Menu Search
Equities

Healthpeak Properties Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
HC5:FRA

Healthpeak Properties Inc

Actions
  • Price (EUR)14.10
  • Today's Change0.000 / 0.00%
  • Shares traded3.14k
  • 1 Year change-27.32%
  • Beta1.1053
Data delayed at least 15 minutes, as of Feb 06 2026 07:36 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. It owns, operates, and develops real estate focused on healthcare discovery and delivery. The Company’s segments include Lab, Outpatient medical and continuing care retirement community (CCRC). The Outpatient medical segment owns, operates, and develops outpatient medical buildings, hospitals, and lab buildings. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. Its CCRC segment is a retirement community that include independent living, assisted living, memory care, and skilled nursing units to provide a continuum of care in an integrated campus.

  • Revenue in USD (TTM)2.82bn
  • Net income in USD70.51m
  • Incorporated2022
  • Employees411.00
  • Location
    Healthpeak Properties Inc4600 South Syracuse Street, Suite 500DENVER 80237United StatesUSA
  • Phone+1 (720) 428-5050
  • Websitehttps://www.healthpeak.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.